Eurofins Scientific SE
ERF
Classement en actions
#1377
Eurofins Scientific SE, together with its subsidiaries, provides various... Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. It provides services, such as agroscience, including biological assessment, consumer and human, environmental safety, product chemistry, regulatory consultancy, and seed services; agro testing; assurance, including sustainability, audit, certification, quality inspection, QA-QC programme, and food and dietary supplement labelling services; biopharma, and clinical diagnostics. The company also offers consumer product testing, which include sustainability, testing, certifications and approvals, expert services and regulatory, inspections, audits, consumer research and sensory evaluation, and training courses; cosmetics and personal care; and electrical and electronics laboratories services. In addition, it provides environment testing, including maritime, water, air, soil, building material, pollution, waste, fuel/oil, microplastics, and radioactivity testing; and food and feed testing that include allergen, audit and certification, authenticity, carbohydrates, consulting, dioxins and POPs, food irradiation, GMO, heavy metal, melamine, microbiology, molecular biology, mycotoxin, nutritional analyses, organic contaminants, pesticide, veterinary drug, vitamin, and residual DNA testing. Further, the company provides forensic, genomic, maritime, materials and engineering, REACH, and sensory and consumer services, as well as in vitro diagnostics and PSS insourcing solutions. The company was founded in 1987 and is headquartered in Luxembourg, Luxembourg.
Prix de l'action
$93.33
Dernière synchronisation: 2026-10-20
Capitalisation boursière
$16.20B
Changement (1 jour)
-0.33%
Changement (1 an)
28.73%
Pays
LU
Échange Eurofins Scientific SE (ERF)
Catégorie
Healthcare
Bénéfices pour Eurofins Scientific SE (ERF)
Bénéfices en Jun 2026 TTM : $862.10M
Selon les derniers rapports financiers de Eurofins Scientific SE, les bénéfices actuels de l'entreprise sont de $862.10M. En 2024, l'entreprise a réalisé un bénéfice de $577.10M, une augmentation par rapport à celui de 2023 qui était de $467.94M. Les bénéfices affichés sur cette page correspondent aux bénéfices avant intérêts et impôts, appelés aussi EBIT.
Historique des bénéfices pour Eurofins Scientific SE de 2002 à 2026
Bénéfices à la fin de chaque année
| Année | Bénéfices | Changez |
|---|---|---|
| 2026 (TTM) | $862.10M | 12.35% |
| 2025 | $767.32M | 32.96% |
| 2024 | $577.10M | 23.33% |
| 2023 | $467.94M | -44.07% |
| 2022 | $836.69M | -30.36% |
| 2021 | $1.20B | 42.07% |
| 2020 | $845.69M | 177.62% |
| 2019 | $304.62M | -8.54% |
| 2018 | $333.07M | 10.99% |
| 2017 | $300.10M | 17.56% |
| 2016 | $255.27M | 77.62% |
| 2015 | $143.72M | 17.22% |
| 2014 | $122.61M | 0.11% |
| 2013 | $122.48M | 13.68% |
| 2012 | $107.74M | 18.11% |
| 2011 | $91.22M | 88.59% |
| 2010 | $48.37M | -1,720.16% |
| 2009 | $-2.99M | -107.78% |
| 2008 | $38.37M | -9.89% |
| 2007 | $42.58M | 4.56% |
| 2006 | $40.72M | 46.24% |
| 2005 | $27.85M | 72.80% |
| 2004 | $16.11M | 196.15% |
| 2003 | $5.44M | 145.28% |
| 2002 | $2.22M | 0.00% |
Bénéfices des entreprises similaires ou concurrentes
| Entreprise | Bénéfices | Différence de bénéfices | Pays |
|---|---|---|---|
| $7.61B | 782.61% |
US
|
|
| $4.76B | 452.37% |
US
|
|
| $-252.70M | -129.31% |
US
|
|
| - | - |
CN
|
|
| $1.66B | 92.32% |
US
|
